While CD103+ CD8 TRM reportedly contribute to the antitumor immunity with the production of IFNγ and granzymes in multiple solid cancers, benign T cells in CTCL lesions possess less TRM phenotype with Th2-biased suppressive property. This evidence concerns the gene ITGAE and primary cutaneous T-cell non-Hodgkin lymphoma.